| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.10e-08 | 21 | 158 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.00e-07 | 35 | 158 | 6 | GO:0015020 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.24e-07 | 37 | 158 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.00e-07 | 38 | 158 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.19e-06 | 11 | 158 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.55e-06 | 14 | 158 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.18e-05 | 38 | 158 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | ST3GAL4 ST3GAL6 UGT2B4 UGT2B7 UGT2B15 UGT2B17 PYGB CERCAM PYGL UGT2B28 UGT2B11 | 1.91e-05 | 288 | 158 | 11 | GO:0016757 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT2B4 UGT2B7 UGT2B15 UGT2B17 PYGB CERCAM PYGL UGT2B28 UGT2B11 | 4.77e-05 | 211 | 158 | 9 | GO:0016758 |
| GeneOntologyMolecularFunction | retinoic acid binding | 6.66e-05 | 28 | 158 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.01e-04 | 12 | 158 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.66e-04 | 14 | 158 | 3 | GO:0015386 | |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 1.86e-04 | 3 | 158 | 2 | GO:0008184 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.03e-04 | 37 | 158 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.09e-04 | 107 | 158 | 6 | GO:0033293 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.19e-04 | 153 | 158 | 7 | GO:0008194 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 2.52e-04 | 16 | 158 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.63e-04 | 18 | 158 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | satellite DNA binding | 3.69e-04 | 4 | 158 | 2 | GO:0003696 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 4.29e-04 | 19 | 158 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.75e-04 | 46 | 158 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | retinoid binding | 5.60e-04 | 48 | 158 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 6.06e-04 | 49 | 158 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 6.13e-04 | 5 | 158 | 2 | GO:0004645 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 6.46e-04 | 239 | 158 | 8 | GO:0031406 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.53e-04 | 136 | 158 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | lipid binding | SESTD1 CPNE8 HIP1 TIMD4 FGD2 CYTH3 CYTH2 CYTH1 SNX29 ESYT3 SLC9A3 CD36 UGT2B4 UGT2B7 UGT2B15 UGT2B17 BAIAP3 CYTH4 | 8.42e-04 | 988 | 158 | 18 | GO:0008289 |
| GeneOntologyMolecularFunction | organic acid binding | 9.59e-04 | 254 | 158 | 8 | GO:0043177 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRG3 SLC9A9 TRPC4AP MRS2 TSPOAP1 OCA2 GRIN1 GRIN2D CPOX SLC9C1 SLC9A3 KCNT2 SLC12A9 SLC25A23 ABCC10 | 1.02e-03 | 758 | 158 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC9A9 TRPC4AP MRS2 TSPOAP1 GRIN1 GRIN2D CPOX SLC9C1 SLC9A3 KCNT2 SLC12A9 | 1.21e-03 | 465 | 158 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.24e-03 | 27 | 158 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 1.27e-03 | 7 | 158 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity | 1.27e-03 | 7 | 158 | 2 | GO:0003836 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.34e-03 | 152 | 158 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.38e-03 | 28 | 158 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.69e-03 | 8 | 158 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.69e-03 | 8 | 158 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.16e-03 | 167 | 158 | 6 | GO:0015079 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.31e-03 | 70 | 158 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.10e-03 | 37 | 158 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.58e-03 | 79 | 158 | 4 | GO:0004521 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 4.52e-12 | 8 | 155 | 6 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 3.35e-11 | 10 | 155 | 6 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.45e-10 | 12 | 155 | 6 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 8.08e-09 | 21 | 155 | 6 | GO:0052695 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.23e-08 | 38 | 155 | 7 | GO:0008209 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.32e-08 | 26 | 155 | 6 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.32e-08 | 26 | 155 | 6 | GO:0006063 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.19e-07 | 52 | 155 | 7 | GO:0008210 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.13e-07 | 37 | 155 | 6 | GO:0042178 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 3.13e-07 | 37 | 155 | 6 | GO:0042537 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.08e-06 | 13 | 155 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 2.27e-05 | 8 | 155 | 3 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 2.43e-05 | 23 | 155 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 2.90e-05 | 24 | 155 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.96e-05 | 48 | 155 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | MYLK GRIN1 TLR3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 | 4.76e-05 | 222 | 155 | 9 | GO:0071466 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 5.61e-05 | 2 | 155 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 9.63e-05 | 141 | 155 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.67e-04 | 3 | 155 | 2 | GO:0021627 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 4.70e-07 | 40 | 155 | 6 | GO:0005640 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.08e-04 | 13 | 155 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | cell projection membrane | GABRG3 EVC2 FGD2 GRIN1 ADGRV1 ACE ABCA7 SLC9C1 SLC9A3 CD36 IQCE | 3.82e-04 | 431 | 155 | 11 | GO:0031253 |
| Domain | UDPGT | 1.15e-08 | 21 | 149 | 6 | PF00201 | |
| Domain | UDPGT | 1.15e-08 | 21 | 149 | 6 | PS00375 | |
| Domain | UDP_glucos_trans | 1.15e-08 | 21 | 149 | 6 | IPR002213 | |
| Domain | - | 4.96e-06 | 15 | 149 | 4 | 1.10.1000.11 | |
| Domain | Sec7 | 4.96e-06 | 15 | 149 | 4 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.96e-06 | 15 | 149 | 4 | IPR023394 | |
| Domain | SEC7 | 6.57e-06 | 16 | 149 | 4 | PS50190 | |
| Domain | Sec7 | 6.57e-06 | 16 | 149 | 4 | SM00222 | |
| Domain | Sec7_dom | 6.57e-06 | 16 | 149 | 4 | IPR000904 | |
| Domain | Plexin_cytopl | 4.04e-05 | 9 | 149 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 4.04e-05 | 9 | 149 | 3 | IPR013548 | |
| Domain | Plexin | 4.04e-05 | 9 | 149 | 3 | IPR031148 | |
| Domain | Cation/H_exchanger_CPA1 | 7.83e-05 | 11 | 149 | 3 | IPR018422 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.70e-04 | 14 | 149 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.70e-04 | 14 | 149 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.70e-04 | 14 | 149 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.70e-04 | 14 | 149 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.70e-04 | 14 | 149 | 3 | IPR011704 | |
| Domain | Na_H_Exchanger | 1.70e-04 | 14 | 149 | 3 | PF00999 | |
| Domain | MT | 1.70e-04 | 14 | 149 | 3 | PF12777 | |
| Domain | Cation/H_exchanger | 1.70e-04 | 14 | 149 | 3 | IPR006153 | |
| Domain | AAA_8 | 1.70e-04 | 14 | 149 | 3 | PF12780 | |
| Domain | AAA_5 | 1.70e-04 | 14 | 149 | 3 | PF07728 | |
| Domain | PHOSPHORYLASE | 1.89e-04 | 3 | 149 | 2 | PS00102 | |
| Domain | Glycg_phsphrylas | 1.89e-04 | 3 | 149 | 2 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.89e-04 | 3 | 149 | 2 | IPR000811 | |
| Domain | Phosphorylase | 1.89e-04 | 3 | 149 | 2 | PF00343 | |
| Domain | DHC_fam | 2.11e-04 | 15 | 149 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.11e-04 | 15 | 149 | 3 | PF03028 | |
| Domain | LY | 2.11e-04 | 15 | 149 | 3 | SM00135 | |
| Domain | Dynein_heavy_dom | 2.11e-04 | 15 | 149 | 3 | IPR004273 | |
| Domain | LDLR_classB_rpt | 2.11e-04 | 15 | 149 | 3 | IPR000033 | |
| Domain | IPT | 1.26e-03 | 27 | 149 | 3 | SM00429 | |
| Domain | Ig_E-set | 1.47e-03 | 104 | 149 | 5 | IPR014756 | |
| Domain | Znf_U1 | 1.56e-03 | 29 | 149 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.56e-03 | 29 | 149 | 3 | SM00451 | |
| Domain | DHC_N1 | 1.72e-03 | 8 | 149 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.72e-03 | 8 | 149 | 2 | IPR013594 | |
| Domain | Semap_dom | 1.90e-03 | 31 | 149 | 3 | IPR001627 | |
| Domain | SEMA | 1.90e-03 | 31 | 149 | 3 | PS51004 | |
| Domain | TIG | 1.90e-03 | 31 | 149 | 3 | PF01833 | |
| Domain | Sema | 1.90e-03 | 31 | 149 | 3 | SM00630 | |
| Domain | Sema | 1.90e-03 | 31 | 149 | 3 | PF01403 | |
| Domain | IPT | 2.08e-03 | 32 | 149 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 2.08e-03 | 32 | 149 | 3 | IPR002165 | |
| Domain | PSI | 2.08e-03 | 32 | 149 | 3 | PF01437 | |
| Domain | Calx_beta | 2.19e-03 | 9 | 149 | 2 | IPR003644 | |
| Domain | NaH_exchanger | 2.19e-03 | 9 | 149 | 2 | IPR004709 | |
| Domain | Calx-beta | 2.19e-03 | 9 | 149 | 2 | PF03160 | |
| Domain | RNaseH-like_dom | 2.25e-03 | 69 | 149 | 4 | IPR012337 | |
| Domain | ZF_CCHC | 2.70e-03 | 35 | 149 | 3 | PS50158 | |
| Domain | ANF_lig-bd_rcpt | 3.17e-03 | 37 | 149 | 3 | IPR001828 | |
| Domain | ANF_receptor | 3.17e-03 | 37 | 149 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 3.69e-03 | 39 | 149 | 3 | IPR028082 | |
| Domain | - | 3.69e-03 | 39 | 149 | 3 | 2.120.10.30 | |
| Domain | VWFA | 4.20e-03 | 82 | 149 | 4 | PS50234 | |
| Domain | VWA | 4.58e-03 | 84 | 149 | 4 | SM00327 | |
| Domain | PSI | 5.19e-03 | 44 | 149 | 3 | IPR016201 | |
| Domain | Rho_GTPase_activation_prot | 5.40e-03 | 88 | 149 | 4 | IPR008936 | |
| Domain | Ldl_recept_b | 5.40e-03 | 14 | 149 | 2 | PF00058 | |
| Domain | LDLRB | 5.40e-03 | 14 | 149 | 2 | PS51120 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.88e-03 | 46 | 149 | 3 | IPR011042 | |
| Domain | PSI | 5.88e-03 | 46 | 149 | 3 | SM00423 | |
| Domain | - | 5.88e-03 | 46 | 149 | 3 | 4.10.400.10 | |
| Domain | AAA | 5.99e-03 | 144 | 149 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 5.99e-03 | 144 | 149 | 5 | IPR003593 | |
| Domain | Sialyl_trans | 6.20e-03 | 15 | 149 | 2 | IPR012163 | |
| Domain | LDLRA_1 | 6.62e-03 | 48 | 149 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 7.01e-03 | 49 | 149 | 3 | IPR002172 | |
| Domain | LDLa | 7.01e-03 | 49 | 149 | 3 | SM00192 | |
| Domain | LDLRA_2 | 7.01e-03 | 49 | 149 | 3 | PS50068 | |
| Domain | Methyltransf_11 | 7.05e-03 | 16 | 149 | 2 | IPR013216 | |
| Domain | Methyltransf_11 | 7.05e-03 | 16 | 149 | 2 | PF08241 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | PGM2L1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 PYGB PYGL UGT2B28 UGT2B11 | 4.35e-10 | 52 | 119 | 9 | M14171 |
| Pathway | REACTOME_PREDNISONE_ADME | 2.86e-08 | 23 | 119 | 6 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.79e-08 | 24 | 119 | 6 | MM14599 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 4.53e-08 | 41 | 119 | 7 | M7399 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.95e-08 | 25 | 119 | 6 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.95e-08 | 25 | 119 | 6 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.95e-08 | 25 | 119 | 6 | M605 | |
| Pathway | WP_GLUCURONIDATION | 6.39e-08 | 26 | 119 | 6 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.03e-07 | 28 | 119 | 6 | M19580 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.71e-07 | 55 | 119 | 7 | M14933 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.28e-07 | 39 | 119 | 6 | MM15695 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.73e-06 | 44 | 119 | 6 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.98e-06 | 45 | 119 | 6 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.21e-06 | 51 | 119 | 6 | M17726 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 1.06e-05 | 17 | 119 | 4 | M2482 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.60e-05 | 64 | 119 | 6 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.69e-05 | 70 | 119 | 6 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.16e-05 | 72 | 119 | 6 | M9257 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 5.32e-05 | 25 | 119 | 4 | M47716 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 9.74e-05 | 29 | 119 | 4 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 1.12e-04 | 30 | 119 | 4 | M47738 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 1.22e-04 | 12 | 119 | 3 | MM1342 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 2.57e-04 | 37 | 119 | 4 | MM15354 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.88e-04 | 107 | 119 | 6 | MM14595 | |
| Pathway | REACTOME_DRUG_ADME | 3.18e-04 | 109 | 119 | 6 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.18e-04 | 109 | 119 | 6 | M18788 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 5.05e-04 | 44 | 119 | 4 | M27652 | |
| Pathway | REACTOME_DRUG_ADME | 5.09e-04 | 119 | 119 | 6 | MM15692 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 6.95e-04 | 5 | 119 | 2 | M47667 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 6.95e-04 | 5 | 119 | 2 | MM15655 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 9.14e-04 | 183 | 119 | 7 | M39588 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 1.04e-03 | 6 | 119 | 2 | M47668 | |
| Pubmed | 6.02e-14 | 7 | 160 | 6 | 26074487 | ||
| Pubmed | 2.40e-13 | 8 | 160 | 6 | 32093886 | ||
| Pubmed | 4.31e-10 | 4 | 160 | 4 | 10652308 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.15e-09 | 5 | 160 | 4 | 12629516 | |
| Pubmed | 2.15e-09 | 5 | 160 | 4 | 12920129 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVFC1-1 ERVK-18 ERVK-19 ERVK-25 ERVK-11 | 1.34e-08 | 94 | 160 | 8 | 21542922 |
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 18719240 | ||
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 20142249 | ||
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 17398095 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 19572376 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 18042453 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 29138287 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 7835904 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 10516026 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 28882566 | ||
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 23223495 | ||
| Pubmed | Complex regulation of multiple cytohesin-like genes in murine tissues and cells. | 9.56e-08 | 3 | 160 | 3 | 9744817 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.07e-07 | 12 | 160 | 4 | 20308471 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 12606567 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 3.81e-07 | 4 | 160 | 3 | 8570614 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.81e-07 | 4 | 160 | 3 | 10469592 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 7983737 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 26176234 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 FLNC HIP1 CLTCL1 CYTH3 CYTH1 UBE3B GRIN2D REV3L ABCA7 SH3BP4 BMP4 STRN4 LRP4 PYGB PLXNA1 ABCC10 CYTH4 IQCE | 8.84e-07 | 1105 | 160 | 19 | 35748872 |
| Pubmed | 9.49e-07 | 5 | 160 | 3 | 15318931 | ||
| Pubmed | 1.26e-06 | 18 | 160 | 4 | 18664271 | ||
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 1.58e-06 | 19 | 160 | 4 | 30674481 | |
| Pubmed | INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signaling. | 1.89e-06 | 6 | 160 | 3 | 30355448 | |
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 20056642 | ||
| Pubmed | Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. | 3.30e-06 | 7 | 160 | 3 | 10520994 | |
| Pubmed | 5.10e-06 | 54 | 160 | 5 | 25496667 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 15661641 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 22579593 | ||
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 10748067 | ||
| Pubmed | FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex. | 5.26e-06 | 8 | 160 | 3 | 20080746 | |
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 19909241 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 17846866 | ||
| Pubmed | 1.12e-05 | 10 | 160 | 3 | 12970426 | ||
| Pubmed | 1.38e-05 | 66 | 160 | 5 | 19898482 | ||
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 25315821 | ||
| Pubmed | 1.80e-05 | 34 | 160 | 4 | 23293290 | ||
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 18161889 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 2.04e-05 | 12 | 160 | 3 | 21270798 | |
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 14557543 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10222050 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17343268 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 32660355 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25736709 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28962835 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15083369 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 1909870 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24121496 | ||
| Pubmed | Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains. | 2.10e-05 | 2 | 160 | 2 | 12559962 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17263731 | ||
| Pubmed | Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer. | 2.10e-05 | 2 | 160 | 2 | 36347965 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24267955 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 30967597 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22170718 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15319348 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 2.10e-05 | 2 | 160 | 2 | 3105095 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17848572 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27496708 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22700726 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17698910 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.10e-05 | 2 | 160 | 2 | 9460924 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17687269 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 2.10e-05 | 2 | 160 | 2 | 3117546 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14734633 | ||
| Pubmed | Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor. | 2.10e-05 | 2 | 160 | 2 | 9050849 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21679149 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31601460 | ||
| Pubmed | UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway. | 2.10e-05 | 2 | 160 | 2 | 34400880 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24791904 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28228532 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 2.10e-05 | 2 | 160 | 2 | 11672541 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15666817 | ||
| Pubmed | 2.29e-05 | 251 | 160 | 8 | 29031500 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNC XRN2 CLTCL1 DYNC2H1 RPS15A PRPF8 ACE OGDH DNAH1 NBAS TONSL PYGB PEAK1 HYDIN | 2.38e-05 | 807 | 160 | 14 | 30575818 |
| Pubmed | 2.64e-05 | 13 | 160 | 3 | 10520995 | ||
| Pubmed | 5.12e-05 | 16 | 160 | 3 | 17356169 | ||
| Pubmed | 6.20e-05 | 17 | 160 | 3 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 6.20e-05 | 17 | 160 | 3 | 17626059 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 31022698 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 22486492 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 26385605 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 8333863 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 22972996 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 9971820 | ||
| Pubmed | Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. | 6.29e-05 | 3 | 160 | 2 | 1385220 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 19781661 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 19203752 | ||
| Pubmed | Genotype distributions in top-level soccer players: a role for ACE? | 6.29e-05 | 3 | 160 | 2 | 19277943 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 37369587 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 32176075 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 35867797 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 8806646 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 6.29e-05 | 3 | 160 | 2 | 26163549 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20736324 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17566078 | ||
| Interaction | IPCEF1 interactions | 1.01e-06 | 11 | 153 | 4 | int:IPCEF1 | |
| Cytoband | 4q13 | 1.88e-07 | 15 | 160 | 4 | 4q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.00e-05 | 157 | 160 | 6 | chr4q13 | |
| GeneFamily | UDP glucuronosyltransferases | 2.51e-08 | 32 | 104 | 6 | 363 | |
| GeneFamily | Plexins | 1.51e-05 | 9 | 104 | 3 | 683 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.00e-05 | 15 | 104 | 3 | 529 | |
| GeneFamily | Glycogen phosphorylases | 9.79e-05 | 3 | 104 | 2 | 437 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 6.75e-04 | 7 | 104 | 2 | 1201 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.22e-03 | 206 | 104 | 6 | 682 | |
| GeneFamily | Low density lipoprotein receptors | 2.45e-03 | 13 | 104 | 2 | 634 | |
| GeneFamily | Dyneins, axonemal | 4.21e-03 | 17 | 104 | 2 | 536 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 5.82e-03 | 20 | 104 | 2 | 1371 | |
| GeneFamily | Sialyltransferases | 5.82e-03 | 20 | 104 | 2 | 438 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 2.49e-06 | 103 | 153 | 7 | MM919 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP | 2.72e-06 | 199 | 153 | 9 | M4886 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 1.45e-05 | 53 | 153 | 5 | MM1203 | |
| Coexpression | HOFFMAN_CLOCK_TARGETS_UP | 2.27e-05 | 10 | 153 | 3 | M2063 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 184 | 153 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 184 | 153 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 184 | 153 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 189 | 153 | 8 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-07 | 189 | 153 | 8 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.90e-07 | 195 | 153 | 8 | 45d1acd316d0ced97dfb150c3a943128d8fa4e7e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.21e-07 | 197 | 153 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.55e-07 | 199 | 153 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.72e-07 | 200 | 153 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 160 | 153 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 160 | 153 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 169 | 153 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 175 | 153 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-06 | 184 | 153 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 185 | 153 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-06 | 188 | 153 | 7 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-06 | 189 | 153 | 7 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.17e-06 | 189 | 153 | 7 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.47e-06 | 191 | 153 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.47e-06 | 191 | 153 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.95e-06 | 194 | 153 | 7 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.30e-06 | 196 | 153 | 7 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-06 | 198 | 153 | 7 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-06 | 198 | 153 | 7 | 829377071f65016d31d09175a43c28e95532b404 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-06 | 198 | 153 | 7 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.66e-06 | 198 | 153 | 7 | 27a3c1c5ac855dff8d63f44eaa289be3f5bd621a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-06 | 198 | 153 | 7 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.66e-06 | 198 | 153 | 7 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.85e-06 | 199 | 153 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.85e-06 | 199 | 153 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-06 | 200 | 153 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.73e-06 | 133 | 153 | 6 | a1bc34e5dda4ff4716b857931cc196f6770f58f4 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.67e-06 | 139 | 153 | 6 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 153 | 153 | 6 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 161 | 153 | 6 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 169 | 153 | 6 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 169 | 153 | 6 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-05 | 171 | 153 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 172 | 153 | 6 | 1aecc98a3eadabae0f1f328091a9733d916017ec | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 174 | 153 | 6 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 174 | 153 | 6 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.09e-05 | 174 | 153 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 175 | 153 | 6 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-05 | 176 | 153 | 6 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 178 | 153 | 6 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 178 | 153 | 6 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 178 | 153 | 6 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.51e-05 | 178 | 153 | 6 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.74e-05 | 180 | 153 | 6 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | facs-Heart-RA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 181 | 153 | 6 | c68d272eb41f81bd8ea4d0360733a2396bc87037 | |
| ToppCell | facs-Heart-RA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 181 | 153 | 6 | 5e5eb89f224ee48065a328ade030cbc4dcdcac12 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-05 | 184 | 153 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.49e-05 | 186 | 153 | 6 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.49e-05 | 186 | 153 | 6 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.49e-05 | 186 | 153 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.49e-05 | 186 | 153 | 6 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 187 | 153 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.63e-05 | 187 | 153 | 6 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 187 | 153 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 187 | 153 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-05 | 187 | 153 | 6 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 187 | 153 | 6 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 188 | 153 | 6 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 188 | 153 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.91e-05 | 189 | 153 | 6 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 189 | 153 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 190 | 153 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 190 | 153 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 190 | 153 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 190 | 153 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-05 | 191 | 153 | 6 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-05 | 191 | 153 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-05 | 191 | 153 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.36e-05 | 192 | 153 | 6 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-05 | 192 | 153 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.36e-05 | 192 | 153 | 6 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 192 | 153 | 6 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 192 | 153 | 6 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| Computational | Genes in the cancer module 227. | 7.25e-06 | 15 | 95 | 4 | MODULE_227 | |
| Drug | C1 11-32 | 1.51e-09 | 18 | 154 | 6 | CID000443077 | |
| Drug | C11131 | 1.51e-09 | 18 | 154 | 6 | CID000443076 | |
| Drug | AC1Q6OQG | 2.08e-09 | 33 | 154 | 7 | CID000009686 | |
| Drug | T4-G | 2.19e-09 | 19 | 154 | 6 | CID000152424 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 3.24e-09 | 35 | 154 | 7 | CID010436171 | |
| Drug | estriol-16-glucuronide | 4.33e-09 | 21 | 154 | 6 | CID000122281 | |
| Drug | estradiol-3-glucuronide | 7.97e-09 | 23 | 154 | 6 | CID000066651 | |
| Drug | 3-OHBaP | 1.03e-08 | 63 | 154 | 8 | CID000025890 | |
| Drug | testosterone glucuronide | 1.05e-08 | 41 | 154 | 7 | CID000108192 | |
| Drug | 2-AF | 1.05e-08 | 41 | 154 | 7 | CID000005800 | |
| Drug | L-idaro-1,4-lactone | 2.89e-08 | 28 | 154 | 6 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 3.63e-08 | 29 | 154 | 6 | CID000125641 | |
| Drug | chrysin | CYP19A1 TONSL UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 4.40e-08 | 106 | 154 | 9 | CID005281607 |
| Drug | benzyloxyresorufin | 5.73e-08 | 78 | 154 | 8 | CID000114982 | |
| Drug | oxazepam | 6.71e-08 | 53 | 154 | 7 | CID000004616 | |
| Drug | BP-3,6-quinol | 8.27e-08 | 33 | 154 | 6 | CID000119292 | |
| Drug | 7-methoxycoumarin | 1.12e-07 | 57 | 154 | 7 | CID000010748 | |
| Drug | AC1NOWCJ | 1.20e-07 | 35 | 154 | 6 | CID005120112 | |
| Drug | estrone-3-glucuronide | 1.20e-07 | 35 | 154 | 6 | CID000115255 | |
| Drug | 7-ethoxycoumarin | 1.24e-07 | 86 | 154 | 8 | CID000035703 | |
| Drug | 4-hydroxybiphenyl | 1.43e-07 | 59 | 154 | 7 | CID000007103 | |
| Drug | acetaminophen glucuronide | 1.43e-07 | 59 | 154 | 7 | CID000083944 | |
| Drug | SN-38G | 1.43e-07 | 59 | 154 | 7 | CID000443154 | |
| Drug | l-borneol | 1.70e-07 | 37 | 154 | 6 | CID000010049 | |
| Drug | hexobarbital | GABRG3 CYP19A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 2.10e-07 | 127 | 154 | 9 | CID000003608 |
| Drug | SecinH3 | 2.47e-07 | 9 | 154 | 4 | CID001029232 | |
| Drug | harmol | 2.76e-07 | 40 | 154 | 6 | CID000068094 | |
| Drug | DB04103 | 3.17e-07 | 97 | 154 | 8 | CID004469987 | |
| Drug | 1-naphthol | 3.43e-07 | 98 | 154 | 8 | CID000007005 | |
| Drug | oltipraz | HNF1A ADGRV1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 ZNF44 | 4.02e-07 | 137 | 154 | 9 | CID000047318 |
| Drug | methoxyresorufin | 4.29e-07 | 69 | 154 | 7 | CID000119220 | |
| Drug | androsterone glucuronide | 4.31e-07 | 43 | 154 | 6 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 4.31e-07 | 43 | 154 | 6 | CID000009191 | |
| Drug | MS-222 | 4.96e-07 | 44 | 154 | 6 | CID000011400 | |
| Drug | Hymecromone | 6.32e-07 | 25 | 154 | 5 | ctd:D006923 | |
| Drug | eugenol | 6.33e-07 | 73 | 154 | 7 | CID000003314 | |
| Drug | 2,2,2-trichloroethanol | 6.33e-07 | 73 | 154 | 7 | CID000008259 | |
| Drug | 2 E1 | HNF1A CYP19A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 6.49e-07 | 145 | 154 | 9 | CID006102788 |
| Drug | fluconazole | 6.75e-07 | 107 | 154 | 8 | CID000003365 | |
| Drug | salicylamide | 8.43e-07 | 48 | 154 | 6 | CID000005147 | |
| Drug | AC1N8H7N | 9.98e-07 | 78 | 154 | 7 | CID004318740 | |
| Drug | acridine | 1.29e-06 | 81 | 154 | 7 | CID000009215 | |
| Drug | disulfiram | AGXT2 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 MXI1 | 1.33e-06 | 158 | 154 | 9 | CID000003117 |
| Drug | AC1Q7AUJ | 1.33e-06 | 117 | 154 | 8 | CID000003303 | |
| Drug | AC1NQGK1 | 1.37e-06 | 52 | 154 | 6 | CID005195977 | |
| Drug | alpha-naphthoflavone | 1.42e-06 | 118 | 154 | 8 | CID000011790 | |
| Drug | AC1LCF1F | UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 BAIAP3 ABCC10 | 1.56e-06 | 161 | 154 | 9 | CID000627275 |
| Drug | 5 alpha-androstane | 1.65e-06 | 84 | 154 | 7 | CID000094144 | |
| Drug | pentoxyresorufin | 2.10e-06 | 87 | 154 | 7 | CID000107683 | |
| Drug | aminopyrine | CYP19A1 CPOX UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 2.57e-06 | 171 | 154 | 9 | CID000006009 |
| Drug | phenolphthalein | 2.63e-06 | 58 | 154 | 6 | CID000004764 | |
| Drug | urochloralic acid | 2.91e-06 | 59 | 154 | 6 | CID003036914 | |
| Drug | 4-hydroxyestrone | 2.91e-06 | 59 | 154 | 6 | CID000018418 | |
| Drug | phenolphthalin | 3.00e-06 | 5 | 154 | 3 | CID000066494 | |
| Drug | Amobarbital | 3.00e-06 | 5 | 154 | 3 | ctd:D000654 | |
| Drug | p-nitroanisole | 3.06e-06 | 92 | 154 | 7 | CID000007485 | |
| Drug | UDP-alpha-d-xylopyranose | 3.22e-06 | 60 | 154 | 6 | CID000001165 | |
| Drug | 2-naphthol | 3.29e-06 | 93 | 154 | 7 | CID000008663 | |
| Drug | ethoxyresorufin | 3.79e-06 | 95 | 154 | 7 | CID000003294 | |
| Drug | DCNB | 3.79e-06 | 95 | 154 | 7 | CID000007443 | |
| Drug | UDP - Na | ARID5A UGT2B4 UGT2B7 UGT2B15 UGT2B17 PYGB PYGL UGT2B28 UGT2B11 MBD2 | 4.75e-06 | 235 | 154 | 10 | CID000001158 |
| Drug | arabinosyluracil | ERVK-6 TNPO2 PRPF8 UGT2B4 UGT2B7 UGT2B15 UGT2B17 PYGB PYGL TSHZ1 UGT2B28 UGT2B11 | 5.50e-06 | 354 | 154 | 12 | CID000001177 |
| Drug | lorcaserin | 5.98e-06 | 6 | 154 | 3 | ctd:C506658 | |
| Drug | butylated hydroxytoluene | 6.00e-06 | 143 | 154 | 8 | CID000031404 | |
| Drug | 3-hydroxyandrostan-17-one | 6.09e-06 | 102 | 154 | 7 | CID000000225 | |
| Drug | benzo(a)pyrene | CYP19A1 CPOX REV3L TSKU UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 BAIAP3 | 6.16e-06 | 358 | 154 | 12 | CID000002336 |
| Drug | phenobarbital | GABRG3 CYP19A1 GRIN2D MSTN TONSL UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 6.52e-06 | 360 | 154 | 12 | CID000004763 |
| Drug | Meldola | 6.73e-06 | 68 | 154 | 6 | CID000081507 | |
| Drug | epicholesterol | HNF1A ERBB3 CLTCL1 CYP19A1 APCS ACE MSTN ABCA7 AGXT2 CD36 TLR3 TONSL UGT2B4 LRP4 LRP6 MBD2 | 6.87e-06 | 636 | 154 | 16 | CID000000304 |
| Drug | glycylglycylglycine | 7.21e-06 | 40 | 154 | 5 | CID000011161 | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 8.14e-06 | 197 | 154 | 9 | 4642_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A | LARP6 SH3BP2 BMP4 DNAJC28 TINF2 N4BP1 BAIAP3 SLC25A23 PLXNA1 | 8.47e-06 | 198 | 154 | 9 | 2653_DN |
| Drug | halazepam | 8.96e-06 | 20 | 154 | 4 | CID000031640 | |
| Drug | AC1L1OBF | 8.96e-06 | 20 | 154 | 4 | CID000032736 | |
| Drug | phenolate | COQ3 SLC9A3 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 BAIAP3 ZNF44 | 9.41e-06 | 254 | 154 | 10 | CID000000996 |
| Drug | ranirestat | 1.04e-05 | 7 | 154 | 3 | ctd:C115070 | |
| Drug | 7-hydroxycoumarin | 1.19e-05 | 75 | 154 | 6 | CID005281426 | |
| Drug | 16-epiestriol | 1.39e-05 | 77 | 154 | 6 | CID000003269 | |
| Drug | ethoxyquin | 1.42e-05 | 116 | 154 | 7 | CID000003293 | |
| Drug | fibrates | 1.59e-05 | 118 | 154 | 7 | CID000002797 | |
| Drug | benzphetamine | 1.68e-05 | 119 | 154 | 7 | CID000002341 | |
| Drug | estrone-d4 | 1.95e-05 | 168 | 154 | 8 | CID000000698 | |
| Drug | glucosiduronate | 2.21e-05 | 171 | 154 | 8 | CID000000610 | |
| Drug | 5-Iodoribose 1-phosphate | 2.47e-05 | 9 | 154 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 2.47e-05 | 9 | 154 | 3 | CID000107502 | |
| Drug | buthionine sulfoximine | TONSL UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 BAIAP3 ABCC10 | 2.70e-05 | 229 | 154 | 9 | CID000021157 |
| Drug | menthol | 2.79e-05 | 87 | 154 | 6 | CID000001254 | |
| Drug | AC1L1FK5 | 2.83e-05 | 129 | 154 | 7 | CID000003272 | |
| Drug | 3-methylcholanthrene | HNF1A CYP19A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 2.89e-05 | 231 | 154 | 9 | CID000001674 |
| Drug | licochalcone A | 3.13e-05 | 27 | 154 | 4 | ctd:C070840 | |
| Drug | 3 -hydroxypregn-5-en-20-one | GABRG3 CYP19A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 MBD2 | 3.64e-05 | 238 | 154 | 9 | CID000001027 |
| Drug | SN-38 | ST3GAL4 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B28 UGT2B11 ABCC10 | 3.73e-05 | 184 | 154 | 8 | CID000104842 |
| Drug | 4-aminobiphenyl | 3.84e-05 | 92 | 154 | 6 | CID000007102 | |
| Drug | 3 alpha,6 alpha-dihydroxy-5 beta-cholanoic acid | 4.19e-05 | 29 | 154 | 4 | CID000006747 | |
| Drug | DNCB | 4.52e-05 | 189 | 154 | 8 | CID000000006 | |
| Drug | 5-(2-chloroethyl)uracil | 4.55e-05 | 2 | 154 | 2 | CID010442204 | |
| Drug | 6878P | 4.55e-05 | 2 | 154 | 2 | CID002725013 | |
| Drug | AC1LBRFU | 4.55e-05 | 2 | 154 | 2 | CID000562981 | |
| Drug | 1,5-dihydroxynaphthalene | 4.55e-05 | 2 | 154 | 2 | ctd:C028289 | |
| Drug | 2-hydroxyestriol | 4.55e-05 | 2 | 154 | 2 | ctd:C008012 | |
| Disease | X-19141 measurement | 3.70e-09 | 13 | 148 | 5 | EFO_0800799 | |
| Disease | X-24947 measurement | 7.29e-08 | 22 | 148 | 5 | EFO_0800910 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 7.51e-08 | 9 | 148 | 4 | EFO_0600040 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.29e-06 | 118 | 148 | 7 | EFO_0010119 | |
| Disease | alkaline phosphatase measurement | HNF1A EMC1 MRS2 CYP19A1 ST3GAL4 JMJD1C ST3GAL6 SLC12A9 CD36 TONSL UGT2B4 UGT2B7 UGT2B15 UGT2B17 PYGB PYGL UGT2B11 ABCC10 | 3.59e-06 | 1015 | 148 | 18 | EFO_0004533 |
| Disease | Glycosuria | 4.26e-06 | 7 | 148 | 3 | HP_0003076 | |
| Disease | metabolite measurement | CLTCL1 REV3L ACE AGXT2 NBAS CD36 UGT2B4 UGT2B7 UGT2B15 UGT2B17 UGT2B11 C4orf33 PRODH | 5.34e-06 | 560 | 148 | 13 | EFO_0004725 |
| Disease | deoxycholic acid glucuronide measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0800575 | |
| Disease | cerebral infarction (is_implicated_in) | 1.31e-05 | 29 | 148 | 4 | DOID:3526 (is_implicated_in) | |
| Disease | cholic acid glucuronide measurement | 7.47e-05 | 3 | 148 | 2 | EFO_0800574 | |
| Disease | platelet crit | TIMD4 NUP210L ST3GAL4 ADGRV1 ITGAD JMJD1C NUP205 SH3BP4 TGM3 THPO CD36 UBXN2A LY75 CDH3 ABCC10 | 9.31e-05 | 952 | 148 | 15 | EFO_0007985 |
| Disease | phosphatidylcholine 36:4 measurement | 9.55e-05 | 18 | 148 | 3 | EFO_0010382 | |
| Disease | Disorder of eye | 1.02e-04 | 212 | 148 | 7 | C0015397 | |
| Disease | androsterone glucuronide measurement | 1.32e-04 | 20 | 148 | 3 | EFO_0800317 | |
| Disease | X-25937 measurement | 1.49e-04 | 4 | 148 | 2 | EFO_0800937 | |
| Disease | N-glycan measurement | 1.78e-04 | 22 | 148 | 3 | EFO_0004999 | |
| Disease | Coronary heart disease | 2.32e-04 | 24 | 148 | 3 | C0010068 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.32e-04 | 24 | 148 | 3 | DOID:3827 (biomarker_via_orthology) | |
| Disease | total lipids in IDL | 2.38e-04 | 60 | 148 | 4 | EFO_0022161 | |
| Disease | Staphylococcus aureus infection | 2.47e-04 | 5 | 148 | 2 | C1318973 | |
| Disease | Staphylococcal Infections | 2.47e-04 | 5 | 148 | 2 | C0038160 | |
| Disease | disease progression measurement | 2.54e-04 | 61 | 148 | 4 | EFO_0008336 | |
| Disease | Polydactyly | 3.17e-04 | 117 | 148 | 5 | C0152427 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 3.70e-04 | 6 | 148 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | macrophage colony-stimulating factor 1 receptor measurement | 3.70e-04 | 6 | 148 | 2 | EFO_0020547 | |
| Disease | essential thrombocythemia (is_marker_for) | 3.70e-04 | 6 | 148 | 2 | DOID:2224 (is_marker_for) | |
| Disease | complex trait | 4.54e-04 | 271 | 148 | 7 | EFO_0010578 | |
| Disease | docosahexaenoic acid measurement | 4.61e-04 | 127 | 148 | 5 | EFO_0007761 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 4.84e-04 | 274 | 148 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.06e-04 | 276 | 148 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | vanillylmandelate (VMA) measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0800119 | |
| Disease | X-24574 measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0800879 | |
| Disease | asymmetrical dimethylarginine measurement, serum dimethylarginine measurement | 6.04e-04 | 33 | 148 | 3 | EFO_0005418, EFO_0006522 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 6.86e-04 | 8 | 148 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0008151 | |
| Disease | Unilateral agenesis of kidney | 6.86e-04 | 8 | 148 | 2 | C0266294 | |
| Disease | Ovarian Cysts | 7.19e-04 | 35 | 148 | 3 | C0029927 | |
| Disease | Corpus Luteum Cyst | 7.19e-04 | 35 | 148 | 3 | C0010093 | |
| Disease | Kartagener Syndrome | 7.19e-04 | 35 | 148 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 7.19e-04 | 35 | 148 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 7.19e-04 | 35 | 148 | 3 | C4317124 | |
| Disease | vitamin D deficiency | 8.48e-04 | 37 | 148 | 3 | EFO_0003762 | |
| Disease | angiotensin-converting enzyme measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0006515 | |
| Disease | X-12844 measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0021339 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 9.44e-04 | 307 | 148 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | intermediate density lipoprotein measurement | 9.79e-04 | 87 | 148 | 4 | EFO_0008595 | |
| Disease | serum metabolite measurement | GABRG3 HNF1A REV3L ACE ABCA7 SH3BP4 AGXT2 SLC9A3 KCNT2 UGT2B15 SORCS3 C4orf33 PRODH | 9.82e-04 | 945 | 148 | 13 | EFO_0005653 |
| Disease | tooth agenesis (is_implicated_in) | 1.10e-03 | 10 | 148 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0022090 | |
| Disease | vascular endothelial growth factor receptor 3 measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0008315 | |
| Disease | eye color | 1.11e-03 | 90 | 148 | 4 | EFO_0003949 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.16e-03 | 91 | 148 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | autism spectrum disorder | 1.17e-03 | 156 | 148 | 5 | EFO_0003756 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.31e-03 | 94 | 148 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0801531 | |
| Disease | urokinase-type plasminogen activator measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0010803 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.46e-03 | 243 | 148 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | urinary metabolite measurement | 1.52e-03 | 245 | 148 | 6 | EFO_0005116 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 1.58e-03 | 99 | 148 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 1.60e-03 | 12 | 148 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0800291 | |
| Disease | coronary artery disease (is_implicated_in) | 1.64e-03 | 100 | 148 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Primary Ciliary Dyskinesia | 1.71e-03 | 47 | 148 | 3 | C4551720 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.83e-03 | 103 | 148 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | sodium measurement | 1.83e-03 | 103 | 148 | 4 | EFO_0009282 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.88e-03 | 13 | 148 | 2 | EFO_0800293 | |
| Disease | vitamin D measurement, COVID-19 | 1.92e-03 | 49 | 148 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.04e-03 | 50 | 148 | 3 | EFO_0010732 | |
| Disease | gallstones | 2.17e-03 | 108 | 148 | 4 | EFO_0004210 | |
| Disease | urokinase plasminogen activator surface receptor measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0010932 | |
| Disease | atrial fibrillation (is_implicated_in) | 2.19e-03 | 14 | 148 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | response to selective serotonin reuptake inhibitor, openness measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0005658, EFO_0007914 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0800283 | |
| Disease | phospholipids in IDL measurement | 2.28e-03 | 52 | 148 | 3 | EFO_0022164 | |
| Disease | Congestive heart failure | 2.32e-03 | 110 | 148 | 4 | C0018802 | |
| Disease | Heart failure | 2.32e-03 | 110 | 148 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 2.32e-03 | 110 | 148 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 2.32e-03 | 110 | 148 | 4 | C0235527 | |
| Disease | Heart Decompensation | 2.32e-03 | 110 | 148 | 4 | C1961112 | |
| Disease | Myocardial Failure | 2.32e-03 | 110 | 148 | 4 | C1959583 | |
| Disease | Ciliopathies | 2.32e-03 | 110 | 148 | 4 | C4277690 | |
| Disease | mean reticulocyte volume | TIMD4 NUP210L ABCA7 JMJD1C NUP205 CD36 TONSL LY75 MBD2 CDH3 ABCC10 | 2.39e-03 | 799 | 148 | 11 | EFO_0010701 |
| Disease | unipolar depression, autism spectrum disorder | 2.51e-03 | 15 | 148 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | factor VII measurement | 2.68e-03 | 55 | 148 | 3 | EFO_0004619 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.70e-03 | 189 | 148 | 5 | EFO_0009932 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 2.86e-03 | 16 | 148 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | galectin-3 measurement | 2.86e-03 | 16 | 148 | 2 | EFO_0008137 | |
| Disease | free androgen index | 2.89e-03 | 374 | 148 | 7 | EFO_0007005 | |
| Disease | cholesterol in IDL measurement | 3.12e-03 | 58 | 148 | 3 | EFO_0021899 | |
| Disease | renal fibrosis (implicated_via_orthology) | 3.23e-03 | 17 | 148 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.28e-03 | 121 | 148 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | free cholesterol in IDL measurement | 3.60e-03 | 61 | 148 | 3 | EFO_0022181 | |
| Disease | platelet-derived growth factor BB measurement | 3.60e-03 | 61 | 148 | 3 | EFO_0008264 | |
| Disease | Carcinoma of bladder | 3.63e-03 | 18 | 148 | 2 | C0699885 | |
| Disease | age at onset, Parkinson disease | 3.63e-03 | 18 | 148 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0800288 | |
| Disease | serum dimethylarginine measurement | 3.94e-03 | 63 | 148 | 3 | EFO_0005418 | |
| Disease | hypertension (implicated_via_orthology) | 4.01e-03 | 128 | 148 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 4.04e-03 | 19 | 148 | 2 | DOID:1591 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKVNAVAQKQLGRLW | 121 | Q9BYV1 | |
| LGPQLLLNWGVQIAK | 806 | P21860 | |
| FFLQKPHLQINWTGL | 241 | A0FGR9 | |
| LQASPGKLLWRKFQI | 11 | Q9Y2D0 | |
| IERVPHLGFKQINLW | 76 | Q03989 | |
| SGRRNVWKQELPLSF | 91 | Q8N1A6 | |
| KVLQAGSSRPWQEVL | 571 | P12821 | |
| FLPAVKLWFQVLRDQ | 696 | O94812 | |
| QQGQPLYKDSWLLRE | 81 | Q9H981 | |
| LQIKPGVFNEYRTIW | 46 | Q9NZJ6 | |
| KGGTQLQLLKWPLRF | 36 | P78314 | |
| GLQKFDVNWSPRLNL | 5101 | Q8WXG9 | |
| QFLWSFRLPGEAQKI | 146 | Q9UIA0 | |
| QELVAVSGRKLNWPL | 431 | P16066 | |
| VLRWTREKQPNYGLA | 221 | P12644 | |
| FQSPLRWEVVGKNLL | 1721 | Q8IZY2 | |
| LYPDQGKLWQLLALS | 196 | Q04671 | |
| GKLWQLLALSPLENY | 201 | Q04671 | |
| WLKAQVLERQPKQGG | 116 | O75943 | |
| PNTLDKWFLILRGQQ | 91 | Q6ZRI8 | |
| LQARLTLVGKEGPQW | 241 | O95153 | |
| FVPPNIKQWIALLQR | 96 | Q86XS8 | |
| PDASWVINGLKQRIL | 206 | Q6IPM2 | |
| DSQLWKLPGLQATVR | 316 | Q92621 | |
| QGKLRLQKWYITLPD | 11 | Q96PC3 | |
| PGLNREQLYWELSKL | 12311 | Q8WXI7 | |
| KIPGLDRQQLYWELS | 13246 | Q8WXI7 | |
| LNNFPWVINGLLEAK | 551 | Q5T3U5 | |
| QLLVNLWGPEKTISY | 81 | Q9GZK6 | |
| PWHAGQYEILLKNRV | 786 | Q15746 | |
| LFGEPKRLLTQNWVQ | 351 | P43364 | |
| QNKSKWAIFLPLVLG | 406 | P60608 | |
| ENLKNVPLLDWQGIF | 466 | Q9H9K5 | |
| IQWPALTFKPLVERN | 106 | Q15652 | |
| PLRFWVNVIKNPQFV | 1746 | Q9UIW2 | |
| PLRFWVNVIKNPQFV | 1721 | P51805 | |
| LPLRFWINIIKNPQF | 1981 | O43157 | |
| IENFLQPSKNGLIWR | 606 | Q6PCE3 | |
| QTWTQPRLCYLVKEG | 6 | A8MUH7 | |
| IIGWNRNRAALSQKP | 101 | Q9H792 | |
| ALNLWLGEQLKQLVP | 426 | Q6P474 | |
| ARKQTPKQRLLGWIQ | 156 | Q14315 | |
| NGQLQLKIGRDWVPL | 1321 | Q5H8C1 | |
| RQFLWSFRLPGEAQK | 146 | Q15438 | |
| ILIDNGYQPEWILKQ | 246 | Q9NX36 | |
| WINTLQGKLSILQPL | 196 | Q9HD23 | |
| NDFQKLLGDINWIRP | 266 | P63132 | |
| QELLKRGVPWLFLQQ | 761 | Q86UK5 | |
| GSLRKVLFWQELDQP | 126 | O75581 | |
| VWIGLKNINIPTLFQ | 421 | O60449 | |
| RNRFKWGPASQQILF | 201 | P20823 | |
| KLWALATPQKNGRVQ | 196 | Q9BRS8 | |
| SYKGNIWEQILRIPF | 126 | Q6UVM3 | |
| NLPRGQALLEKWNLI | 221 | O15442 | |
| LPDGLVRLVNKQINW | 76 | A2RRP1 | |
| NDFQKLLGDINWIRP | 266 | P63135 | |
| NDFQKLLGDINWIRP | 266 | Q9BXR3 | |
| ALWKGVQNLVLGAPR | 411 | Q13349 | |
| AVERYQLIVNPRGWK | 131 | Q99463 | |
| NDFQKLLGDINWIRP | 266 | Q9QC07 | |
| EQPRQLFWEKRLQGL | 276 | Q9UBB5 | |
| QAKWVRQNGIVLLLP | 766 | Q02218 | |
| FQIFRKLWGRQIPGT | 236 | O43613 | |
| LQQIIPQGLFWKDDI | 106 | Q5W5W9 | |
| VKIRSWQIAGLPNDT | 3201 | Q9P2D7 | |
| LTPQQHYDWGLRALK | 1856 | Q8NCM8 | |
| LIAWFQQIRAAGLPV | 81 | P07199 | |
| ELLPITNWLNKPQRF | 4746 | Q4G0P3 | |
| TLALWPQIIQKKANG | 531 | Q96PB1 | |
| GIIFNNNPELWKTTR | 131 | P11511 | |
| SASRVQPGLLQWVKF | 461 | Q6E0U4 | |
| TPNQLLRIWNDGKIL | 146 | Q99928 | |
| KRNYIVPILWLNETG | 406 | P16671 | |
| LVQLGRTHKPDWNYI | 2466 | A8TX70 | |
| QFLWSFRLPGEAQKI | 146 | Q99418 | |
| QFLWSFRLPGEAQKI | 151 | O43739 | |
| TAFKQQRLPAWQPIL | 31 | Q9NV96 | |
| VFRPNGIALTWNITK | 586 | Q5U623 | |
| WTANPRIGDVIQKLA | 176 | Q7Z6J4 | |
| KKNLQVIIRGLPVWF | 416 | Q9ULL0 | |
| WLQGSQELPREKYLT | 251 | P01877 | |
| LIRLNIWPAVQGACK | 41 | Q6UWJ8 | |
| LFLQQLAGKVVLWSR | 431 | Q8N766 | |
| NPSKWVLAGVALLLQ | 4471 | Q9NYC9 | |
| WDLIYLGRKQVNPEK | 441 | Q5T4B2 | |
| SFTPQEKLWQQLRRG | 376 | P36551 | |
| NQKISYRILRDPAGW | 471 | P22223 | |
| LNPVWQAFKISVRAL | 206 | Q86YQ8 | |
| WNVQSRGRIFLVSKP | 296 | O15259 | |
| IGIAQVWLPSKRKQN | 701 | Q5VU65 | |
| ILWGNNHFFRINLPK | 531 | Q9H1H9 | |
| RNNKWFTGPQLISLL | 436 | Q92990 | |
| ALINVWIPSVFLRGK | 656 | Q8TEQ0 | |
| LIPGLNNLFDKLIWR | 416 | Q8TEL6 | |
| SFLLNLGRKQKIPWN | 416 | Q8IVB4 | |
| QKLFWQILLISIPGF | 101 | Q4G0N8 | |
| LQLWGKHQFVLSRPQ | 521 | Q9P0V3 | |
| ITYNKGRDWRLLQAP | 516 | Q9UPU3 | |
| QLWGLALNKRRATLP | 6 | Q9Y6E0 | |
| VLQNWLKQPESNLGI | 211 | O14793 | |
| FQGLTIKPLVQWLKV | 451 | P48764 | |
| SIGKWIADNQPRLIQ | 461 | Q92540 | |
| KGAQTFWSVVNRLPL | 71 | O00291 | |
| PQFLLQFSEVLAKWR | 241 | O43272 | |
| INTNGFWKKPALNLI | 206 | Q9Y274 | |
| IWDVNPKQIRILNPF | 221 | Q11206 | |
| SGDTLPRLNRVWKQF | 576 | Q86VW0 | |
| VKLGTFILLFNPWLN | 126 | Q08188 | |
| KNNRPAEGLLQTWLL | 571 | P53675 | |
| NDFQKLLGDINWIRP | 266 | P63136 | |
| SWDRGIPRINTLFQK | 1411 | Q6P2Q9 | |
| PRARTILKWNELNVG | 231 | Q96PU4 | |
| LEKWQNNLLPSRQFG | 86 | P62244 | |
| IGLPKRVVQVWFQNA | 2921 | Q86UP3 | |
| KLLVGDLWNLQALPQ | 211 | Q96MN9 | |
| ILNWPVQKERIGAFR | 876 | O15455 | |
| ILYLSEHQGTLPWQK | 116 | Q6P9A3 | |
| KFTWREGQKQLPLIG | 156 | Q9BYE2 | |
| EIGLPKRVIQVWFQN | 2101 | Q9C0A1 | |
| PIKQIAWEQKQRGFI | 1466 | O60673 | |
| FWINGTPLVKKGLRQ | 126 | P02743 | |
| TRLYKWIPQNDLLGH | 351 | P06133 | |
| QVEAALQPQTLRKWG | 286 | Q86U17 | |
| LQGRPWAQVLKALNH | 71 | Q9BSI4 | |
| GLSPLETLQQWVKLY | 631 | Q96HA7 | |
| NPDANGVTRSWKIIL | 36 | Q8TAQ9 | |
| WQQFSEQFPPLLKER | 876 | O14787 | |
| HVKFWRPQLLLLVGN | 526 | Q9BXP2 | |
| RLNNDPGWKNLTVIL | 181 | Q9H0D6 | |
| NDFQKLLGDINWIRP | 266 | P10266 | |
| QNKTNGITPRRWLLL | 481 | P11216 | |
| EPITNIQIWLANGKR | 171 | P68543 | |
| NDFQKLLGDINWIRP | 266 | Q9UQG0 | |
| IRLPLAKTNLTWYGI | 1466 | P08922 | |
| PAVVQSVLLERGWNK | 96 | Q9BWV7 | |
| TRLYKWIPQNDLLGH | 351 | O75310 | |
| RRPKVNSILNLFGSW | 436 | Q86X10 | |
| ITKQLQFLWGVPLIR | 381 | Q7Z3V4 | |
| LNNGRIPDFRKWAVL | 511 | P86452 | |
| DLQSKAWPRVRQFLQ | 26 | Q9P272 | |
| LWRGNGINVLKIAPE | 241 | Q9BV35 | |
| NSPLVWKEGRQLLRQ | 166 | Q9NRL3 | |
| TRIATLLQQVHGKPW | 401 | Q53H54 | |
| FQKLLGDINWIRPTL | 271 | Q9WJR5 | |
| GLILKRSNRNVPWDL | 106 | O60765 | |
| ASALAQIPQKVLWRF | 326 | P54855 | |
| TRLYKWIPQNDLLGL | 351 | Q9BY64 | |
| SALAQIPQKVLWRFD | 326 | P16662 | |
| TRLYKWIPQNDLLGH | 351 | P16662 | |
| QQRKEPLLPVYLGSW | 471 | Q5VYS8 | |
| PLNWVQFLVIKNGLE | 76 | A6NGA9 | |
| LQVLDLSGNPKLNWA | 256 | Q8WUA8 | |
| QNKTNGITPRRWLLL | 481 | P06737 | |
| WALLGPSQKNLYRDV | 66 | P15621 | |
| VPGWFNDVKINVRLN | 116 | Q96H15 | |
| KGRQSNWNPQHLLIL | 886 | Q6ZSZ6 | |
| ASALAQIPQKVLWRF | 326 | O75795 | |
| LLWRESQKPQGGILA | 581 | Q9UNY4 | |
| GGTNILSPLKWVIRQ | 436 | Q5TIE3 | |
| SGLLKWQQGFRAKIP | 216 | P40225 | |
| RKVLINTDLGWPNGL | 1506 | O75096 | |
| EQRFLKWRLEQLQGP | 136 | P50539 | |
| KLGNRNITVFVPQWR | 651 | O75113 | |
| VGSWEQQTLRLKYPL | 401 | O15399 | |
| NTNIWKTGPLFKRVL | 311 | Q05586 |